Premium Phosphosite-Specific 7TM Antibodies
Your Resource for GPCR Research
Select Your Country of Delivery below

Chemerin Receptor 2 Antibodies

Close filters
No results were found for the filter!
NEW
Agonist-induced Serine343/Threonine345 phosphorylation of Chemerin Receptor 2
pS343/pT345-CMKLR2 (phospho-Chemerin Receptor 2...
Serine343/Threonine345 (S343/T345) is a major phosphorylation site of the Chemerin receptor 2 (CMKLR2). The pS343/pT345-CMKLR2 antibody detects phosphorylation in response to high-efficacy agonists. S343/T345 phosphorylation is a key...
$ 375.00 *
NEW
Agonist-induced Threonine335/Serine337 phosphorylation of Chemerin Receptor 2
pT335/pS337-CMKLR2 (phospho-Chemerin Receptor 2...
Threonine335/Serine337 (T335/S337) is a major phosphorylation site of the Chemerin receptor 2 (CMKLR2). The pT335/pS337-CMKLR2 antibody detects phosphorylation in response to high-efficacy agonists. T335/S337 phosphorylation is a key...
$ 375.00 *
NEW
Agonist-induced Serine331/Serine333 phosphorylation of Chemerin Receptor 2
pS331/pS333-CMKLR2 (phospho-Chemerin Receptor 2...
Serine331/Serine333 (S331/S333) is a major phosphorylation site of the Chemerin receptor 2 (CMKLR2). The pS331/pS333-CMKLR2 antibody detects phosphorylation in response to high-efficacy agonists. S331/S333 phosphorylation is a key...
$ 375.00 *

Chemerin receptor 2, encoded by GPR1, is a class A G protein-coupled receptor activated by the adipokine chemerin. The chemerin-derived C-terminal nonapeptide C9 also activates GPR1 and is used as an experimental agonist. In recombinant systems, human GPR1 recruits β-arrestins robustly but shows relatively weak G protein signaling. Chemerin stimulation promotes β-arrestin recruitment and receptor internalization, and agonist-independent association with β-arrestin has also been observed. GPR1 can internalize bound chemerin in cell-based assays, suggesting a role in regulating local chemerin availability. GPR1 expression has been reported in adipose tissue and skeletal muscle, and studies in knockout mice suggest that it contributes to glucose homeostasis under high-fat feeding. Its physiological role in humans remains incompletely understood. No GPR1-selective ligand has been reported to enter clinical trials or receive approval for therapeutic use. The Chemerin2 receptor is regulated by phosphorylation of carboxyl-terminal serine331/serine333 (pS331/pS333-CMKLR2), threonine335/serine337 (pT335/pS337-CMKLR2) and serine343/threonine345 (pS343/pT345-CMKLR2). This nomenclature refers to the human CMKLR2. This phosphorylation motif is highly conserved across species and nearly identical in mice, rats and humans. For more information on CMKLR2 pharmacology please refer to the IUPHAR database. For further reading refer to:

Kennedy AJ, Davenport AP. International Union of Basic and Clinical Pharmacology CIII: Chemerin Receptors CMKLR1 (Chemerin1) and GPR1 (Chemerin2) Nomenclature, Pharmacology, and Function. Pharmacol Rev. 2018 Jan;70(1):174-196. doi: 10.1124/pr.116.013177. Epub 2017 Dec 26. PMID: 29279348

Davenport AP, Monaghan AE. Chemerin receptors (version 2019.3) in the IUPHAR/BPS Guide to Pharmacology Database. IUPHAR/BPS Guide to Pharmacology CITE. 2019; 2019(3). Available from: https://doi.org/10.2218/gtopdb/F338/2021.3.

Chemerin receptor 2, encoded by GPR1 , is a class A G protein-coupled receptor activated by the adipokine chemerin. The chemerin-derived C-terminal nonapeptide C9 also activates GPR1 and is... read more »
Close window
Chemerin Receptor 2 Antibodies

Chemerin receptor 2, encoded by GPR1, is a class A G protein-coupled receptor activated by the adipokine chemerin. The chemerin-derived C-terminal nonapeptide C9 also activates GPR1 and is used as an experimental agonist. In recombinant systems, human GPR1 recruits β-arrestins robustly but shows relatively weak G protein signaling. Chemerin stimulation promotes β-arrestin recruitment and receptor internalization, and agonist-independent association with β-arrestin has also been observed. GPR1 can internalize bound chemerin in cell-based assays, suggesting a role in regulating local chemerin availability. GPR1 expression has been reported in adipose tissue and skeletal muscle, and studies in knockout mice suggest that it contributes to glucose homeostasis under high-fat feeding. Its physiological role in humans remains incompletely understood. No GPR1-selective ligand has been reported to enter clinical trials or receive approval for therapeutic use. The Chemerin2 receptor is regulated by phosphorylation of carboxyl-terminal serine331/serine333 (pS331/pS333-CMKLR2), threonine335/serine337 (pT335/pS337-CMKLR2) and serine343/threonine345 (pS343/pT345-CMKLR2). This nomenclature refers to the human CMKLR2. This phosphorylation motif is highly conserved across species and nearly identical in mice, rats and humans. For more information on CMKLR2 pharmacology please refer to the IUPHAR database. For further reading refer to:

Kennedy AJ, Davenport AP. International Union of Basic and Clinical Pharmacology CIII: Chemerin Receptors CMKLR1 (Chemerin1) and GPR1 (Chemerin2) Nomenclature, Pharmacology, and Function. Pharmacol Rev. 2018 Jan;70(1):174-196. doi: 10.1124/pr.116.013177. Epub 2017 Dec 26. PMID: 29279348

Davenport AP, Monaghan AE. Chemerin receptors (version 2019.3) in the IUPHAR/BPS Guide to Pharmacology Database. IUPHAR/BPS Guide to Pharmacology CITE. 2019; 2019(3). Available from: https://doi.org/10.2218/gtopdb/F338/2021.3.

Recently viewed